Signaling and aging at the neuromuscular synapse: Lessons learnt from neuromuscular diseases

Current Opinion in Pharmacology

Volumn 12, Issue 3, 2012, Pages 340-346

  Punga, Anna Rostedt ^a   Ruegg, Markus A ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; DYSTROBREVIN; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4; MUSCLE SPECIFIC TYROSINE KINASE; PROTEIN TYROSINE KINASE; SALBUTAMOL; UNCLASSIFIED DRUG;

ACTION POTENTIAL; AGING; ARTICLE; CHOLINE ACETYLTRANSFERASE GENE; CONGENITAL MYASTHENIC SYNDROME; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWNSTREAM OF KINASE 7 GENE; EATON LAMBERT SYNDROME; GENE; GENE MUTATION; HUMAN; MUSCLE ATROPHY; MUSCLE SPECIFIC TYROSINE KINASE GENE; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAPSYN GENE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84862291962     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.02.002     Document Type: Review

References (48)

1. A.R. Punga, S. Lin, F. Oliveri, S. Meinen, and M.A. Ruegg Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice Exp Neurol 230 2011 207 217
2. N. Kim, and S.J. Burden MuSK controls where motor axons grow and form synapses Nat Neurosci 11 2008 19 27
3. F. Chen, Y. Liu, Y. Sugiura, P.D. Allen, R.G. Gregg, and W. Lin Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors Nat Neurosci 14 2011 570 577
4. S. Lin, M. Maj, G. Bezakova, J.P. Magyar, H.R. Brenner, and M.A. Ruegg Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice Proc Natl Acad Sci USA 105 2008 11406 11411
5. G. Bezakova, and M.A. Ruegg New insights into the roles of agrin Nat Rev Mol Cell Biol 4 2003 295 308
6. T. Misgeld, T.T. Kummer, J.W. Lichtman, and J.R. Sanes Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter Proc Natl Acad Sci USA 102 2005 11088 11093
7. G. Jones, T. Meier, M. Lichtsteiner, V. Witzemann, B. Sakmann, and H.R. Brenner Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle Proc Natl Acad Sci USA 94 1997 2654 2659
8. N. Kim, A.L. Stiegler, T.O. Cameron, P.T. Hallock, A.M. Gomez, J.H. Huang, S.R. Hubbard, M.L. Dustin, and S.J. Burden Lrp4 is a receptor for Agrin and forms a complex with MuSK Cell 135 2008 334 342
9. B. Zhang, S. Luo, Q. Wang, T. Suzuki, W.C. Xiong, and L. Mei LRP4 serves as a coreceptor of agrin Neuron 60 2008 285 297
10. D.J. Glass, D.C. Bowen, T.N. Stitt, C. Radziejewski, J. Bruno, T.E. Ryan, D.R. Gies, S. Shah, K. Mattsson, and S.J. Burden Agrin acts via a MuSK receptor complex Cell 85 1996 513 523
11. K. Okada, A. Inoue, M. Okada, Y. Murata, S. Kakuta, T. Jigami, S. Kubo, H. Shiraishi, K. Eguchi, and M. Motomura The muscle protein Dok-7 is essential for neuromuscular synaptogenesis Science 312 2006 1802 1805
12. M. Gautam, P.G. Noakes, J. Mudd, M. Nichol, G.C. Chu, J.R. Sanes, and J.P. Merlie Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice Nature 377 1995 232 236
13. S. Pun, M. Sigrist, A.F. Santos, M.A. Ruegg, J.R. Sanes, T.M. Jessell, S. Arber, and P. Caroni An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles Neuron 34 2002 357 370
14. C.R. Slater Reliability of neuromuscular transmission and how it is maintained Handb Clin Neurol 91 2008 27 101
15. L. Schaeffer, A. de Kerchove d'Exaerde, and J.P. Changeux Targeting transcription to the neuromuscular synapse Neuron 31 2001 15 22
16. M. Akaaboune, S.M. Culican, S.G. Turney, and J.W. Lichtman Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo Science 286 1999 503 507
17. G. Bezakova, I. Rabben, I. Sefland, G. Fumagalli, and T. Lomo Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers Proc Natl Acad Sci USA 98 2001 9924 9929
18. E. Bruneau, D. Sutter, R.I. Hume, and M. Akaaboune Identification of nicotinic acetylcholine receptor recycling and its role in maintaining receptor density at the neuromuscular junction in vivo J Neurosci 25 2005 9949 9959
19. P. Escher, E. Lacazette, M. Courtet, A. Blindenbacher, L. Landmann, G. Bezakova, K.C. Lloyd, U. Mueller, and H.R. Brenner Synapses form in skeletal muscles lacking neuregulin receptors Science 308 2005 1920 1923
20. N. Schmidt, M. Akaaboune, N. Gajendran, I. Martinez-Pena y Valenzuela, S. Wakefield, R. Thurnheer, and H.R. Brenner Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of alpha-dystrobrevin J Cell Biol 195 2011 1171 1184
21. P. Mittaud, P.A. Marangi, S. Erb-Vogtli, and C. Fuhrer Agrin-induced activation of acetylcholine receptor-bound Src family kinases requires Rapsyn and correlates with acetylcholine receptor clustering J Biol Chem 276 2001 14505 14513
22. A.R. Punga, M. Maj, S. Lin, S. Meinen, and M.A. Ruegg MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity Eur J Neurosci 33 2011 890 898
23. W. Hoch, J. McConville, S. Helms, J. Newsom-Davis, A. Melms, and A. Vincent Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies Nat Med 7 2001 365 368
24. O. Higuchi, J. Hamuro, M. Motomura, and Y. Yamanashi Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis Ann Neurol 69 2011 418 422
25. R.N. Cole, S.W. Reddel, O.L. Gervasio, and W.D. Phillips Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction Ann Neurol 63 2008 782 789
26. Y. Kawakami, M. Ito, M. Hirayama, K. Sahashi, B. Ohkawara, A. Masuda, H. Nishida, N. Mabuchi, A.G. Engel, and K. Ohno Anti-MuSK autoantibodies block binding of collagen Q to MuSK Neurology 77 2011 1819 1826
27. S. Mori, S. Kubo, T. Akiyoshi, S. Yamada, T. Miyazaki, H. Hotta, J. Desaki, M. Kishi, T. Konishi, and Y. Nishino Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis Am J Pathol 180 2012 798 810
28. A. Evoli, P.A. Tonali, L. Padua, M.L. Monaco, F. Scuderi, A.P. Batocchi, M. Marino, and E. Bartoccioni Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis Brain 126 2003 2304 2311
29. M.E. Farrugia, M.D. Robson, L. Clover, P. Anslow, J. Newsom-Davis, R. Kennett, D. Hilton-Jones, P.M. Matthews, and A. Vincent MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis Brain 129 2006 1481 1492
30. A.R. Punga, R. Flink, H. Askmark, and E.V. Stalberg Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody Muscle Nerve 34 2006 111 115
31. M. Motomura, I. Johnston, B. Lang, A. Vincent, and J. Newsom-Davis An improved diagnostic assay for Lambert-Eaton myasthenic syndrome J Neurol Neurosurg Psychiatry 58 1995 85 87
32. A.G. Engel, K. Ohno, and S.M. Sine Sleuthing molecular targets for neurological diseases at the neuromuscular junction Nat Rev Neurosci 4 2003 339 352
33. K. Ohno, A. Tsujino, J.M. Brengman, C.M. Harper, Z. Bajzer, B. Udd, R. Beyring, S. Robb, F.J. Kirkham, and A.G. Engel Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans Proc Natl Acad Sci USA 98 2001 2017 2022
34. C. Huze, S. Bauche, P. Richard, F. Chevessier, E. Goillot, K. Gaudon, A. Ben Ammar, A. Chaboud, I. Grosjean, and H.A. Lecuyer Identification of an agrin mutation that causes congenital myasthenia and affects synapse function Am J Hum Genet 85 2009 155 167
35. R.A. Maselli, J.J. Ng, J.A. Anderson, O. Cagney, J. Arredondo, C. Williams, H.B. Wessel, H. Abdel-Hamid, and R.L. Wollmann Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome J Med Genet 46 2009 203 208
36. F. Chevessier, B. Faraut, A. Ravel-Chapuis, P. Richard, K. Gaudon, S. Bauche, C. Prioleau, R. Herbst, E. Goillot, and C. Ioos MUSK, a new target for mutations causing congenital myasthenic syndrome Hum Mol Genet 13 2004 3229 3240
37. D. Beeson, O. Higuchi, J. Palace, J. Cossins, H. Spearman, S. Maxwell, J. Newsom-Davis, G. Burke, P. Fawcett, and M. Motomura Dok-7 mutations underlie a neuromuscular junction synaptopathy Science 313 2006 1975 1978
38. D. Lashley, J. Palace, S. Jayawant, S. Robb, and D. Beeson Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7 Neurology 74 2010 1517 1523
39. J. Senderek, J.S. Muller, M. Dusl, T.M. Strom, V. Guergueltcheva, I. Diepolder, S.H. Laval, S. Maxwell, J. Cossins, and S. Krause Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect Am J Hum Genet 88 2011 162 172
40. V. Guergueltcheva, J.S. Muller, M. Dusl, J. Senderek, A. Oldfors, C. Lindbergh, S. Maxwell, J. Colomer, C.J. Mallebrera, and A. Nascimento Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations J Neurol 2011 10.1007/s00415-011-6262-z [Epub ahead of print]
41. R. Roubenoff, and V.A. Hughes Sarcopenia: current concepts J Gerontol A Biol Sci Med Sci 55 2000 M716 M724
42. G. Valdez, J.C. Tapia, H. Kang, G.D. Clemenson Jr., F.H. Gage, J.W. Lichtman, and J.R. Sanes Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise Proc Natl Acad Sci USA 107 2010 14863 14868
43. Y. Li, Y. Lee, and W.J. Thompson Changes in aging mouse neuromuscular junctions are explained by degeneration and regeneration of muscle fiber segments at the synapse J Neurosci 31 2011 14910 14919
44. Y. Li, and W.J. Thompson Nerve terminal growth remodels neuromuscular synapses in mice following regeneration of the postsynaptic muscle fiber J Neurosci 31 2011 13191 13203
45. L. Butikofer, A. Zurlinden, M.F. Bolliger, B. Kunz, and P. Sonderegger Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia FASEB J 25 2011 4378 4393
46. T. Liewluck, D. Selcen, and A.G. Engel Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia Muscle Nerve 44 2011 789 794
47. W.O. Kline, F.J. Panaro, H. Yang, and S.C. Bodine Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol J Appl Physiol 102 2007 740 747
48. M.A. Ruegg, and D.J. Glass Molecular mechanisms and treatment options for muscle wasting diseases Annu Rev Pharmacol Toxicol 51 2011 373 395